ArticleBiologia futura2026
Antibacterial, antioxidant, and xanthine-oxidase inhibitory screening studies of selected cyperaceae species occurring in Europe.
Article in Biologia futura, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants belonging to the family Cyperaceae are used in traditional medicine worldwide to treat various diseases. The present study focuses on the antibacterial, antioxidant, and xanthine-oxidase inhibitory screening of 41 Cyperaceae species from genera Carex, Cladium, and Schoenoplectus, occurring in the Carpathian Basin. This study evaluated 123 fractions with different polarities (n-hexane, chloroform, and ethyl acetate) of 41 extracts for their antibacterial, antioxidant (DPPH and ORAC assays), and xanthine oxidase (XO)-inhibitory activities. Mainly the ethyl acetate fractions of Carex elata, C. hartmaniorum, C. melanostachya, C. montana, C. morrowii, C. oshimensis, C. petriei, and C. siderosticta displayed high antibacterial activity (inhibition zones > 15 mm) against one or more bacterial strains. In the case of Schoenoplectus lacustris and Carex petriei, also the ethyl acetate fractions showed remarkable antioxidant effects. In contrast, several chloroform extracts possessed XO-inhibitory activity. For Carex siderosticta, C. sylvatica, and Cladium mariscus, the results of the DPPH tests correlated well with those of the ORAC tests; these sedges demonstrated high antioxidant activities in both assays. Based on the results, especially Carex buxbaumii, C. rostrata, C. muskingumensis, C. oshimensis, C. montana, C. siderosticta, C. sylvatica, and Cladium mariscus are considered worthy of activity-guided phytochemical investigations to identify the specific compounds responsible for the observed activity.
Indexed as
Identifiers
41212502What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.